These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
1. [Reduction of exercise inudced hyperventilation by blocking beta adrenergic receptors]. Scheen A; Juchmes J; Cession-Fossion A C R Seances Soc Biol Fil; 1976; 170(1):220-3. PubMed ID: 9186 [TBL] [Abstract][Full Text] [Related]
2. Isoprenaline antagonism and duration of action in exercise induced tachycardia of three -adrenoceptor blocking drugs: pindolol, LF 17-895 and propranolol. Aellig WH Br J Pharmacol; 1973 Mar; 47(3):621P-622P. PubMed ID: 4147193 [No Abstract] [Full Text] [Related]
3. [Endogenous adrenergic stimulation tests and blood levels of cyclic AMP before and after beta-blocking in humans]. Nami R; Nardi PL; Pizzuti M; D'Ascenzo G; Maioli E; Gennari C Boll Soc Ital Cardiol; 1980; 25(7):755-62. PubMed ID: 6115657 [No Abstract] [Full Text] [Related]
4. Influence of beta-blockade with beta-1-selectivity or intrinsic sympathomimetic activity on some cardiorespiratory responses to exercise. Yonga GO; Oyuga HW; Njeru EK East Afr Med J; 1993 Jul; 70(7):405-8. PubMed ID: 7904931 [TBL] [Abstract][Full Text] [Related]
5. Integrated response to exercise in patients with hypertrophic obstructive cardiomyopathy and effect of beta-adrenergic blockade on oxygen transport. Edwards RH; Kristinsson A; Warrell DA Br Heart J; 1969 May; 31(3):390. PubMed ID: 4396140 [No Abstract] [Full Text] [Related]
6. Decrease of peripheral resistance after acute intravenous application of a new beta-receptor blocking agents, bufuralol HCl. Magometschnigg D; Bonelli J; Hitzenberger G; Kaik G; Korn A Int J Clin Pharmacol Biopharm; 1978 Feb; 16(2):54-8. PubMed ID: 24595 [TBL] [Abstract][Full Text] [Related]
7. beta-blockade, atrial natriuretic peptide and exercise. Kantola I; Tarssanen L; Scheinin M; Ruskoaho H; Viinamäki O; Kaila T Int J Clin Pharmacol Ther; 1996 Jan; 34(1):12-6. PubMed ID: 8688991 [TBL] [Abstract][Full Text] [Related]
8. Effect of beta-receptor blockade upon myocardial hemodynamics and nutritional circulation in the heart. Laddu AR; Somani P; Hardman HF Recent Adv Stud Cardiac Struct Metab; 1973; 3():409-17. PubMed ID: 4157081 [No Abstract] [Full Text] [Related]
9. Influence of beta-blockade with beta-1-selectivity or intrinsic sympathomimetic activity on some metabolic responses to exercise. Yonga GO; Oyuga HW; Njeru EK East Afr Med J; 1993 Jul; 70(7):402-4. PubMed ID: 7904930 [TBL] [Abstract][Full Text] [Related]
10. Effects of pindolol and propranolol on beta adrenergic receptors on human lymphocytes. Hedberg A; Gerber JG; Nies AS; Wolfe BB; Molinoff PB J Pharmacol Exp Ther; 1986 Oct; 239(1):117-23. PubMed ID: 3020227 [TBL] [Abstract][Full Text] [Related]
11. [Changes in effort tolerance in patients with coronary arterial disease following administration of 4 beta-adrenolytic agents (propranolol, visken, oxyprenolol and practolol)]. Adamska-Dyniewska H Wiad Lek; 1973 Jul; 26(13):1201-5. PubMed ID: 4147032 [No Abstract] [Full Text] [Related]
12. [Comparative studies on the influence of beta-receptor blocking agents on different circulatory parameters. I. Experimental results before, during and after loading]. Kirchhoff HW; Kuemmerle HP; von Düsterlho J Int Z Klin Pharmakol Ther Toxikol; 1969 Jul; 2(3):229-45. PubMed ID: 4391093 [No Abstract] [Full Text] [Related]
13. Central hemodynamics of beta-adrenoceptor blocking drugs: beta 1 selectivity versus intrinsic sympathomimetic activity. Svendsen TL J Cardiovasc Pharmacol; 1983; 5 Suppl 1():S21-5. PubMed ID: 6188916 [TBL] [Abstract][Full Text] [Related]
14. The effect of AH 5158, pindolol, propranolol, D-propranolol on acute exercise tolerance in angina pectoris. Boakes AJ; Prichard BN Br J Pharmacol; 1973 Mar; 47(3):673P-674P. PubMed ID: 4147197 [No Abstract] [Full Text] [Related]
15. Elevation of beta-adrenergic receptor density in human lymphocytes after propranolol administration. Aarons RD; Nies AS; Gal J; Hegstrand LR; Molinoff PB J Clin Invest; 1980 May; 65(5):949-57. PubMed ID: 6102572 [TBL] [Abstract][Full Text] [Related]
16. [Beta-adrenergic inhibitors (pharmacologic data and deductions for therapeutic application)]. Salvador M; Marco J; Couderc JJ; Cazard JC Cah Med; 1973 Oct; 14(10):877-82. PubMed ID: 4156916 [No Abstract] [Full Text] [Related]
17. [Decrease in maximum consumption of oxygen after blockage of beta-andrenergic receptors]. Scheen A; Juchmès J; Lennes G; Lecomte J Arch Int Physiol Biochim; 1976 Dec; 84(5):915-23. PubMed ID: 66035 [TBL] [Abstract][Full Text] [Related]
18. Dynamic exercise leads to an increase in circulating ICAM-1: further evidence for adrenergic modulation of cell adhesion. Rehman J; Mills PJ; Carter SM; Chou J; Thomas J; Maisel AS Brain Behav Immun; 1997 Dec; 11(4):343-51. PubMed ID: 9512820 [TBL] [Abstract][Full Text] [Related]
19. Renin-suppressive potency of various beta-adrenergic blocking agents at supine rest and during upright exercise. Bühler FR; Marbet G; Patel U; Burkart F Clin Sci Mol Med Suppl; 1975 Jun; 2():61s-64s. PubMed ID: 28879 [No Abstract] [Full Text] [Related]
20. [Endurance after propranolol in the human execution of a general dynamic exercise]. Camus G; Scheen A; Cession-Fossion A; Juchmes J; Mylle P; Dreezen E C R Seances Soc Biol Fil; 1980; 174(5):919-24. PubMed ID: 6449274 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]